人类痴呆症与勒维体的大脑显示广泛的尿素升高
Melissa Scholefield1, Stephanie J Church1, Sasha Philbert1
1Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9NT, UK.
Parkinsonism & related disorders
|May 24, 2024
概括
勒维体痴呆症 (DLB) 在所有十个研究的大脑区域都显示出广泛的尿素升高. 这些尿素变化在神经退行性疾病中很常见,可能会导致病理.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 神经病理学神经病理学
背景情况:
- 最近的研究表明,在阿尔茨海默病,帕金森病痴呆症,血管痴呆症和亨廷顿病中尿素水平升高.
- 目前尚不清楚Lewy体痴呆症 (DLB) 是否也表现出尿素变化.
研究的目的:
- 这项研究调查了患有莱维体痴呆症 (DLB) 个体的10个大脑区域的尿素干扰.
主要方法:
- 尿素度在20个DLB病例和19个对照中使用超高性能液体染色学-并联质谱法 (UHPLC-MS/MS) 测量.
- 统计分析包括曼-惠特尼U测试,与阿尔茨海默病,帕金森病痴呆症,血管痴呆症和亨廷顿病的现有数据进行比较.
主要成果:
- 勒维体痴呆症 (DLB) 在所有十个研究的大脑区域都显示出广泛的尿素升高.
- 在DLB中尿素升高的程度低于阿尔茨海默病或帕金森病痴呆症,可与亨廷顿病相比较,高于血管痴呆症.
- 子表现出最高的尿素折叠变化,而主要视觉皮层显示出最低的.
结论:
- 尿素升高代表了至少五种不同的神经退行性疾病的共同病理特征.
- 需要进一步的研究来阐明尿素干扰的原因和后果以及它们在神经退行性疾病病理学中的作用.
相关概念视频
Dementia
111
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
111
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Alzheimer's Disease: Overview
465
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
465
Parkinson's Disease: Overview
528
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
528
Alzheimer's Disease: Treatment
180
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
180
Parkinson's Disease: Treatment
261
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
261


